Keros Therapeutics, Inc. (KROS)

15.67 -0.04 (-0.25%) USD  |  NASDAQ  |  Feb 24, 12:55
More

Keros Therapeutics Interest Paid Supplemental Data (Quarterly)

Interest Paid Supplemental Data (Quarterly) Chart

View Interest Paid Supplemental Data (Quarterly) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Interest Paid Supplemental Data (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Interest Paid Supplemental Data (Quarterly) Range, Past 5 Years

View Interest Paid Supplemental Data (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Interest Paid Supplemental Data (Quarterly) Benchmarks

View Interest Paid Supplemental Data (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
MannKind Corp. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade